| Known as |
Epoetin delta |
“Drug: Dynepo (Epoetin delta)” NCT00450333 ↗
|
| Known as |
Dynepo |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT00450333 ↗1NCT00514813 ↗
|
| Known as |
Epoetina delta |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2109093 ↗
|
| Known as |
Epoetine delta |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2109093 ↗
|
| Known as |
GA-EPO |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2109093 ↗
|
| Known as |
HMR-4396 |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2109093 ↗
|
| Action |
Activate |
“Erythropoietin receptor agonist” CHEMBL2109093 ↗
|
| Modality |
Protein / enzyme biologic |
— CHEMBL2109093 ↗
|
| Route |
Subcutaneous |
“Subcutaneous injection either BIW, QW, Q2W or Q4W based on what is appropriate for the subject” NCT00514813 ↗
|
| Target |
EPOR |
“Erythropoietin receptor agonist” CHEMBL2109093 ↗
|